DouglasBoyerMuchmoreMD
Endocrinology • La Jolla, CADiabetes, Lipid Metabolism
VP, Endocrinolgoy Clinical Development, Halozyme Therapeutics, Inc
Dr. Muchmore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7037 Via Valverde
La Jolla, CA 92037Phone+1 858-704-8289
Education & Training
University of California San Diego School of MedicineClass of 1975
University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism
Certifications & Licensure
CA State Medical License 1977 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus Start of enrollment: 2009 May 01
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus Start of enrollment: 2010 Aug 01
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 82 citationsSelf-monitoring of blood glucose in overweight type 2 diabetic patientsD. B. Muchmore, J. Springer, M. Miller
Acta Diabetologica. 1994-02-18 - 6 citationsInhaled insulin for controlling blood glucose in patients with diabetesBernard L. Silverman, Christopher J Barnes, Barbara N Campaigne, Douglas B. Muchmore
Vascular Health and Risk Management. 2007-01-01 - 8 citationsSubcutaneous Insulin Administration: Sufficient Progress or Ongoing Need?Ronald J. Pettis, Douglas B. Muchmore, Lutz Heinemann
Journal of Diabetes Science and Technology. 2019-01-01
Press Mentions
Diasome’s Liver Targeted InsulinApril 18th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
